Immunology Screening on the iQue Screener
About this webinar
The following assays will be covered:
- Cell proliferation
- Immunophenotyping
- Cytokine detection
- Cell-mediated killing
This webinar was provided by Intellicyt
IntelliCyt Corporation is the market leader in suspension-cell analysis platforms for immunology and immuno-oncology profiling, antibody discovery, and screening of immune targets in drug discovery and life science research.
IntelliCyt’s iQue Screener can rapidly and cost effectively profile physiologically-relevant model systems for phenotypic endpoints using multiplexed cell and/or bead-based assays.
Our easy-to-use instruments, software, and reagent kits are optimized to work together and designed to conserve precious samples, use less reagent, and minimize time-to-answer. Our high-content solution offers fast and rich per-cell information that delivers the deep insight that complex biology demands.
The top 10 pharmaceutical companies and premier biotechnology and academic institutes, including leaders in immuno-oncology, have made the iQue Screener platform an integral part of their daily research.
View more content from Intellicyt
The rest of this content is restricted - login or subscribe free to access
Why subscribe? Join our growing community of thousands of industry professionals and gain access to:
- quarterly issues in print and/or digital format
- case studies, whitepapers, webinars and industry-leading content
- breaking news and features
- our extensive online archive of thousands of articles and years of past issues
- ...And it's all free!
Click here to Subscribe today Login here
Related topics
Screening
Related organisations
IntelliCyt Corporation